NICOLE WARD: Open Payments
NPI 1558012989 · VINELAND, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$503 in 27 payments from 10 companies in 2025. Trend: 2023 $328 · 2024 $449 · 2025 $503
Food & beverage: $503
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 7 | $129 |
| Sage Therapeutics, LLC | 5 | $92 |
| Sumitomo Pharma America, Inc. | 4 | $72 |
| Exeltis, USA Inc. | 3 | $50 |
| MAYNE PHARMA COMMERCIAL LLC | 2 | $37 |
| Organon LLC | 2 | $36 |
| Exact Sciences Corporation | 1 | $30 |
| Organogenesis Inc. | 1 | $27 |
| Supernus Pharmaceuticals, Inc. | 1 | $16 |
| MILLICENT US INC | 1 | $14 |
Products named: Veozah, ZURZUVAE, MYFEMBREE, SLYND, NEXPLANON, Cologuard Collection Kit, CYGNUS DUAL, Qelbree.
Industry payments across NJ — which companies pay providers there.
